HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Osada Selected Research

Therapeutics

6/2007CLCP1 interacts with semaphorin 4B and regulates motility of lung cancer cells.
1/2007Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis.
10/2000[Hepatic arterial injection of degradable starch microspheres (DSM) combined with adriamycin (ADM) and mitomycin C (MMC) in patients with liver metastasis of colorectal cancer].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Osada Research Topics

Disease

10Neoplasms (Cancer)
01/2021 - 09/2000
10Lung Neoplasms (Lung Cancer)
09/2009 - 05/2000
4Neoplasm Metastasis (Metastasis)
07/2007 - 10/2000
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2009 - 01/2001
2Carcinogenesis
12/2012 - 11/2001
2Leukemia
07/2000 - 03/2000
1Eosinophilia
01/2020
1Neurofibromatosis 2 (Neurofibromatosis Type II)
01/2015
1Malignant Mesothelioma
01/2015
1Bone Resorption
08/2012
1Osteoporosis
08/2012
1Chronic Kidney Failure (Chronic Renal Failure)
04/2008
1Primary Hyperparathyroidism
04/2008
1Glossopharyngeal Nerve Diseases (Glossopharyngeal Neuralgia)
12/2007
1Syncope (Fainting)
12/2007
1B-Cell Lymphoma (Lymphoma, B Cell)
09/2007
1Birth Weight (Birth Weights)
03/2007
1Dyspnea (Shortness of Breath)
01/2007
1Myositis (Idiopathic Inflammatory Myopathies)
01/2007
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2007
1Dermatomyositis (Dermatopolymyositis)
01/2007
1Adenocarcinoma of Lung
11/2005
1Hypersensitivity (Allergy)
12/2001
1Contact Dermatitis (Eczema, Contact)
12/2001
1Hypoxia (Hypoxemia)
12/2001
1Anaphylaxis (Anaphylactic Shock)
12/2001
1Pulmonary Hypertension
12/2001
1Inflammation (Inflammations)
07/2001
1Colonic Neoplasms (Colon Cancer)
03/2001
1Glioma (Gliomas)
02/2001
1Necrosis
12/2000
1Colorectal Neoplasms (Colorectal Cancer)
10/2000
1Lafora Disease
09/2000
1Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy)
09/2000
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
09/2000
1Fallopian Tube Diseases
05/2000

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
01/2015 - 03/2000
3Phosphotransferases (Kinase)IBA
01/2015 - 03/2000
3Transforming Growth Factor beta (TGF-beta)IBA
11/2005 - 05/2000
2Biological ProductsIBA
08/2014 - 05/2000
2Interleukin-10 (Interleukin 10)IBA
05/2001 - 03/2001
2AngiopoietinsIBA
05/2001 - 02/2001
2Antineoplastic Agents (Antineoplastics)IBA
07/2000 - 03/2000
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2020
1AsbestosIBA
01/2015
1Neurofibromin 2 (Merlin)IBA
12/2012
1Tartrate-Resistant Acid PhosphataseIBA
08/2012
1OsteoprotegerinIBA
08/2012
1Alkaline PhosphataseIBA
08/2012
1Reactive Oxygen Species (Oxygen Radicals)IBA
09/2009
1TubulinIBA
01/2009
1MicroRNAs (MicroRNA)IBA
09/2007
1Antisense OligonucleotidesIBA
09/2007
1Homeodomain Proteins (Proteins, Homeobox)IBA
07/2007
1Semaphorins (Semaphorin)IBA
06/2007
1Factor V (Coagulation Factor V)IBA
06/2007
1methyl 4-azidophenylacetimidate (APAI)IBA
03/2007
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2007
1Oxygen (Dioxygen)IBA
01/2007
1AntibodiesIBA
01/2007
1Brain Natriuretic Peptide (Natrecor)FDA Link
12/2001
1Protein Tyrosine PhosphatasesIBA
12/2001
1Picryl Chloride (Trinitrochlorobenzene)IBA
12/2001
1Atrial Natriuretic Factor (ANF)IBA
12/2001
1dinitrophenyl-bovine serum albuminIBA
12/2001
1Immunoglobulin E (IgE)IBA
12/2001
1theasinensin AIBA
11/2001
1Histones (Histone)IBA
11/2001
1Transforming Growth Factor-beta Type II ReceptorIBA
11/2001
1Transforming Growth Factors (Transforming Growth Factor)IBA
11/2001
1Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
11/2001
1lucilactaeneIBA
10/2001
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
07/2001
1CytokinesIBA
03/2001
1ThrombospondinsIBA
03/2001
1Angiopoietin-2IBA
02/2001
1Angiopoietin-1IBA
02/2001
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2001
1MitogensIBA
12/2000
1LigandsIBA
12/2000
1degradable starch microspheresIBA
10/2000
1Mitomycin (Mitomycin-C)FDA LinkGeneric
10/2000
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2000
1Dual-Specificity PhosphatasesIBA
09/2000
1Protein Isoforms (Isoforms)IBA
09/2000
1CamptothecinIBA
03/2000
1Myelin Basic ProteinIBA
03/2000
1Fluorouracil (Carac)FDA LinkGeneric
03/2000
1Protein Kinases (Protein Kinase)IBA
03/2000
1cytotrienin AIBA
03/2000
1Paclitaxel (Taxol)FDA LinkGeneric
03/2000

Therapy/Procedure

3Drug Therapy (Chemotherapy)
01/2021 - 01/2009
3Therapeutics
06/2007 - 10/2000
1Radiotherapy
01/2021
1Aftercare (After-Treatment)
01/2020
1Oral Administration
08/2014
1Renal Dialysis (Hemodialysis)
04/2008
1Microvascular Decompression Surgery
12/2007
1Thoracotomy
06/2000
1General Anesthesia
05/2000